lipoxin a4 has been researched along with Scleroderma, Systemic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akhmetshina, A; Dees, C; Distler, JH; Distler, O; Krönke, G; Lang, V; Palumbo, K; Reich, N; Schett, G; Scholtysek, C; Uderhardt, S; Zerr, P | 1 |
Bodzenta-Lukaszyk, A; Distler, O; Gay, RE; Gay, S; Kowal, K; Kowal-Bielecka, O; Michel, BA; Rojewska, J; Sierakowski, S | 1 |
2 other study(ies) available for lipoxin a4 and Scleroderma, Systemic
Article | Year |
---|---|
The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Bleomycin; Cells, Cultured; Dermis; Eicosanoids; Fibroblasts; Fibrosis; Lipoxins; Mesoderm; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Protein Serine-Threonine Kinases; Scleroderma, Systemic; Transforming Growth Factor beta | 2012 |
Cyclooxygenase- and lipoxygenase-derived eicosanoids in bronchoalveolar lavage fluid from patients with scleroderma lung disease: an imbalance between proinflammatory and antiinflammatory lipid mediators.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Dinoprostone; Eicosanoids; Female; Humans; Hydroxyeicosatetraenoic Acids; Leukotriene B4; Lipoxins; Lipoxygenase; Lung Diseases; Male; Middle Aged; Prostaglandin-Endoperoxide Synthases; Respiratory Function Tests; Scleroderma, Systemic | 2005 |